Registro:

Referencias:

• van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., Boon, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma (1991) Science, 254, pp. 1643-1647
• Barker, P.A., Salehi, A., The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease (2002) J. Neurosci. Res., 67, pp. 705-712
• De Smet, C., Loriot, A., Boon, T., Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells (2004) Mol. Cell. Biol., 24, pp. 4781-4790
• De Smet, C., Lurquin, C., Lethe, B., Martelange, V., Boon, T., DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter (1999) Mol. Cell. Biol., 19, pp. 7327-7335
• Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Shinkai, Y., Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9 (2005) Genes. Dev., 19, pp. 815-826
• Tachibana, M., Sugimoto, K., Nozaki, M., Ueda, J., Ohta, T., Ohki, M., Fukuda, M., Shinkai, Y., G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis (2002) Genes. Dev., 16, pp. 1779-1791
• James, S.R., Link, P.A., Karpf, A.R., Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b (2006) Oncogene, 25, pp. 6975-6985
• Vatolin, S., Abdullaev, Z., Pack, S.D., Flanagan, P.T., Custer, M., Loukinov, D.I., Pugacheva, E., Lobanenkov, V.V., Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes (2005) Cancer Res., 65, pp. 7751-7762
• Yang, B., O'Herrin, S., Wu, J., Reagan-Shaw, S., Ma, Y., Nihal, M., Longley, B.J., Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo (2007) J. Invest. Dermatol., 127, pp. 267-275
• Gaudet, F., Hodgson, J.G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J.W., Leonhardt, H., Jaenisch, R., Induction of tumors in mice by genomic hypomethylation (2003) Science, 300, pp. 489-492
• Shin, K.C., Choi, E.Y., Chung, J.H., Jeon, C., Lee, K.H., Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy (2012) Anticancer Res., 32, pp. 163-167
• Hussein, Y.M., Ghareib, A.F., Mohamed, R.H., Radwan, M.I., Elsawy, W.H., MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma (2011) Med. Oncol.
• Kim, H., Kim, S.J., Lee, S.H., Seong, H.S., Lee, K.O., Jeon, C.H., Hong, Y.J., Kim, T.H., Usefulness of melanoma antigen (MAGE) gene analysis in tissue samples from percutaneous needle aspiration biopsy of suspected lung cancer lesions (2010) Lung Cancer, 69, pp. 284-288
• Caballero, O.L., Chen, Y.T., Cancer/testis (CT) antigens: potential targets for immunotherapy (2009) Cancer Sci., 100, pp. 2014-2021
• Yang, B., O'Herrin, S.M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K.M., Gravekamp, C., Longley, B.J., MAGE-A, mMAGE-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines (2007) Cancer Res., 67, pp. 9954-9962
• Liu, W., Cheng, S., Asa, S.L., Ezzat, S., The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis (2008) Cancer Res., 68, pp. 8104-8112
• Sang, M., Lian, Y., Zhou, X., Shan, B., MAGE-A family: attractive targets for cancer immunotherapy (2011) Vaccine, 29, pp. 8496-8500
• Sherr, C.J., Weber, J.D., The ARF/p53 pathway (2000) Curr. Opin. Genet. Dev., 10, pp. 94-99
• Helton, E.S., Chen, X., P53 modulation of the DNA damage response (2007) J. Cell Biochem., 100, pp. 883-896
• Vousden, K.H., Lane, D.P., P53 in health and disease (2007) Nat. Rev. Mol. Cell. Biol., 8, pp. 275-283
• Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S.V., Hainaut, P., Olivier, M., Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database (2007) Hum. Mutat., 28, pp. 622-629
• Levine, A.J., The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products: p53 (2009) Virology, 384, pp. 285-293
• Monte, M., Simonatto, M., Peche, L.Y., Bublik, D.R., Gobessi, S., Pierotti, M.A., Rodolfo, M., Schneider, C., MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents (2006) Proc. Natl. Acad. Sci. USA, 103, pp. 11160-11165
• Wang, C., Ivanov, A., Chen, L., Fredericks, W.J., Seto, E., Rauscher, F.J., Chen, J., MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation (2005) Embo. J., 24, pp. 3279-3290
• Wang, C., Rauscher, F.J., Cress, W.D., Chen, J., Regulation of E2F1 function by the nuclear corepressor KAP1 (2007) J. Biol. Chem., 282, pp. 29902-29909
• Doyle, J.M., Gao, J., Wang, J., Yang, M., Potts, P.R., MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases (2010) Mol. Cell., 39, pp. 963-974
• Ivanov, A.V., Peng, H., Yurchenko, V., Yap, K.L., Negorev, D.G., Schultz, D.C., Psulkowski, E., Rauscher, F.J., PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing (2007) Mol. Cell., 28, pp. 823-837
• Feng, Y., Gao, J., Yang, M., When MAGE meets RING: insights into biological functions of MAGE proteins (2011) Protein Cell, 2, pp. 7-12
• Marcar, L., Maclaine, N.J., Hupp, T.R., Meek, D.W., MAGE-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin (2010) Cancer Res., 70, pp. 10362-10370
• Vousden, K.H., Prives, C., Blinded by the light: the growing complexity of p53 (2009) Cell, 137, pp. 413-431
• Liu, B., Chen, Y., St Clair, D.K., ROS and p53: a versatile partnership (2008) Free Radic. Biol. Med., 44, pp. 1529-1535
• Ladelfa, M.F., Toledo, M.F., Laiseca, J.E., Monte, M., Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production (2011) Antioxid. Redox. Sig., 15, pp. 1749-1761
• Peche, L.Y., Scolz, M., Ladelfa, M.F., Monte, M., Schneider, C., MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs (2011) Cell. Death Differ.
• Kepkay, R., Attwood, K.M., Ziv, Y., Shiloh, Y., Dellaire, G., KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin (2011) Cell Cycle, 10, pp. 308-322
• Ziv, Y., Bielopolski, D., Galanty, Y., Lukas, C., Taya, Y., Schultz, D.C., Lukas, J., Shiloh, Y., Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP1 dependent pathway (2006) Nat. Cell. Biol., 8, pp. 870-876
• Cheng, S., Liu, W., Mercado, M., Ezzat, S., Asa, S.L., Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer (2009) Endocr. Relat. Cancer, 16, pp. 455-466
• Nardiello, T., Jungbluth, A.A., Mei, A., Diliberto, M., Huang, X., Dabrowski, A., Andrade, V.C., Cho, H.J., MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin (2011) Clin. Cancer Res., 17, pp. 4309-4319
• Glazer, C.A., Smith, I.M., Bhan, S., Sun, W., Chang, S.S., Pattani, K.M., Westra, W., Califano, J.A., The role of MAGEA2 in head and neck cancer (2011) Arch. Otolaryngol. Head Neck Surg., 137, pp. 286-293
• Taniura, H., Matsumoto, K., Yoshikawa, K., Physical and functional interactions of neuronal growth suppressor necdin with p53 (1999) J. Biol. Chem., 274, pp. 16242-16248
• Taniura, H., Taniguchi, N., Hara, M., Yoshikawa, K., NECDIN, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1 (1998) J. Biol. Chem., 273, pp. 720-728
• Wen, C.J., Xue, B., Qin, W.X., Yu, M., Zhang, M.Y., Zhao, D.H., Gao, X., Li, C.J., HNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation (2004) FEBS Lett., 564, pp. 171-176
• Tian, X.X., Rai, D., Li, J., Zou, C., Bai, Y., Wazer, D., Band, V., Gao, Q., BRCA2 suppresses cell proliferation via stabilizing MAGE-D1 (2005) Cancer Res., 65, pp. 4747-4753
• Salehi, A.H., Roux, P.P., Kubu, C.J., Zeindler, C., Bhakar, A., Tannis, L.L., Verdi, J.M., Barker, P.A., NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis (2000) Neuron, 27, pp. 279-288
• Kendall, S.E., Battelli, C., Irwin, S., Mitchell, J.G., Glackin, C.A., Verdi, J.M., NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade (2005) Mol. Cell. Biol., 25, pp. 7711-7724
• Di Certo, M.G., Corbi, N., Bruno, T., Iezzi, S., De Nicola, F., Desantis, A., Ciotti, M.T., Passananti, C., NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death (2007) J. Cell. Sci., 120, pp. 1852-1858
• Sakurai, T., Itoh, K., Higashitsuji, H., Nagao, T., Nonoguchi, K., Chiba, T., Fujita, J., A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells (2004) J. Biol. Chem., 279, pp. 15505-15514
• Nagao, T., Higashitsuji, H., Nonoguchi, K., Sakurai, T., Dawson, S., Mayer, R.J., Itoh, K., Fujita, J., MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity (2003) J. Biol. Chem., 278, pp. 10668-10674
• Sakurai, T., Kudo, M., Itoh, K., Ryu, U., Higashitsuji, H., Fujita, J., Adriamycin enhances proteasome-mediated generation of the proapoptotic processed form of MAGE-A4 in hepatoma cells (2011) Oncology, 81 (SUPPL. 1), pp. 30-35
• Peikert, T., Specks, U., Farver, C., Erzurum, S.C., Comhair, S.A., Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis (2006) Cancer Res., 66, pp. 4693-4700
• Laduron, S., Deplus, R., Zhou, S., Kholmanskikh, O., Godelaine, D., De Smet, C., Hayward, S.D., De Plaen, E., MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription (2004) Nucl. Acids Res., 32, pp. 4340-4350
• Askew, E.B., Bai, S., Hnat, A.T., Minges, J.T., Wilson, E.M., Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators (2009) J. Biol. Chem., 284, pp. 34793-34808
• Bai, S., Wilson, E.M., Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor (2008) Mol. Cell. Biol., 28, pp. 1947-1963
• Bai, S., He, B., Wilson, E.M., Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction (2005) Mol. Cell. Biol., 25, pp. 1238-1257
• Mohler, J.L., Gregory, C.W., Ford, O.H., Kim, D., Weaver, C.M., Petrusz, P., Wilson, E.M., French, F.S., The androgen axis in recurrent prostate cancer (2004) Clin. Cancer Res., 10, pp. 440-448
• Askew, E.B., Bai, S., Blackwelder, A.J., Wilson, E.M., Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling (2010) J. Biol. Chem., 285, pp. 21824-21836
• Caballero, O.L., Zhao, Q., Rimoldi, D., Stevenson, B.J., Svobodova, S., Devalle, S., Rohrig, U.F., Simpson, A.J., Frequent MAGE mutations in human melanoma (2010) PLoS One, 5
• Klenova, E.M., Morse, H.C., Ohlsson, R., Lobanenkov, V.V., The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer (2002) Semin. Cancer Biol., 12, pp. 399-414
• Hong, J.A., Kang, Y., Abdullaev, Z., Flanagan, P.T., Pack, S.D., Fischette, M.R., Adnani, M.T., Schrump, D.S., Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells (2005) Cancer Res., 65, pp. 7763-7774
• Renaud, S., Loukinov, D., Bosman, F.T., Lobanenkov, V., Benhattar, J., CTCF binds the proximal exonic region of hTERT and inhibits its transcription (2005) Nucl. Acids Res., 33, pp. 6850-6860
• Woloszynska-Read, A., James, S.R., Song, C., Jin, B., Odunsi, K., Karpf, A.R., BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines (2010) Cancer Immun., 10, p. 6
• He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Hannon, G.J., A microRNA component of the p53 tumour suppressor network (2007) Nature, 447, pp. 1130-1134
• Weeraratne, S.D., Amani, V., Neiss, A., Teider, N., Scott, D.K., Pomeroy, S.L., Cho, Y.J., MiR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma (2010) Neur. Oncol., 13, pp. 165-175
• Yamakuchi, M., Ferlito, M., Lowenstein, C.J., MiR-34a repression of SIRT1 regulates apoptosis (2008) Proc. Natl. Acad. Sci. USA, 105, pp. 13421-13426
• Hermeking, H., The miR-34 family in cancer and apoptosis (2010) Cell Death Differ., 17, pp. 193-199
• Sang, M., Wang, L., Ding, C., Zhou, X., Wang, B., Wang, L., Lian, Y., Shan, B., Melanoma-associated antigen genes - an update (2011) Cancer Lett., 302, pp. 85-90
• Ellis, L., Pan, Y., Smyth, G.K., George, D.J., McCormack, C., Williams-Truax, R., Mita, M., Prince, H.M., Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma (2008) Clin. Cancer Res., 14, pp. 4500-4510
• Joseph, J., Mudduluru, G., Antony, S., Vashistha, S., Ajitkumar, P., Somasundaram, K., Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB (2004) Oncogene, 23, pp. 6304-6315
• Hoshino, I., Matsubara, H., Recent advances in histone deacetylase targeted cancer therapy (2010) Surg. Today, 40, pp. 809-815
• Bhatia, N., Yang, B., Xiao, T.Z., Peters, N., Hoffmann, M.F., Longley, B.J., Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP1 (2011) Arch. Biochem. Biophys., 508, pp. 217-221

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------